March 2020 Briefing – Internal Medicine
Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for March 2020. This roundup includes the...
ENDO: Real-World Data Analyzed for Use of Insulin Pump in T1DM
Subgroup analysis shows time spent in target glucose range increased in auto mode versus manual mode
FDA Pulls Heartburn Drug Zantac From Market
Withdrawal of ranitidine products means they will not be available either by prescription or OTC
Phone-Based Therapy Beneficial for Depression in Parkinson Disease
Telephone CBT outperformed treatment-as-usual on all depression, anxiety, quality-of-life measures
Severe COVID-19 Risk Up With Existing Health Conditions in U.S.
Most commonly reported underlying health conditions were diabetes, chronic lung disease, CVD
ENDO: Diabetes Diminishes Weight Loss Effect of Bariatric Surgery
Those without diabetes had increased odds of achieving 50 percent or more excess body-weight loss
ENDO: Real-World Data Analyzed for Use of Insulin Pump in T1DM
Subgroup analysis shows time spent in target glucose range increased in auto mode versus manual mode
Doctors, Hospitals, Pharmacies Warned Not to Stockpile Meds
Professional societies issue stern warning not to inappropriately prescribe meds for COVID-19
FDA Grants First Approval of Convalescent Plasma Therapy in COVID-19 Patient
Houston Methodist first to receive eIND approval for convalescent plasma in individual patient
Inconsistent Bedtime May Affect Cardiovascular Health
Going to bed even 30 minutes later than normal can lead to higher resting heart rates through most of the next day
